| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|
| Total revenues | 3,980,655 | 3,390,119 | 3,321,485 | |
| Cost of revenues | 1,907,359 | 1,801,627 | 1,461,514 | |
| Gross margin | 2,073,296 | 1,588,492 | 1,859,971 | |
| Compensation and related benefits | 1,213,678 | 1,670,460 | 1,658,998 | |
| Goodwill impairment charges | 0 | - | - | |
| General and administrative | 2,917,139 | 2,172,772 | 2,032,291 | |
| Transaction expenses | 0 | 0 | 0 | |
| Total operating expenses | 4,130,817 | 3,843,232 | 3,691,289 | |
| Net operating loss | -2,057,521 | -2,254,740 | -1,831,318 | |
| Interest expense | 755,866 | 240,579 | 730,665 | |
| Other (expense) income, net | -5 | 167,470 | 15,539 | |
| Loss on issuance of financial instruments | - | - | -138,020 | |
| Change in fair value of financial instruments | -2,828,647 | 154,825 | 1,261,471 | |
| Loss on extinguishment of loan | 0 | -126,125 | - | |
| Loss on issuance of financial instruments | -305,000 | 0 | - | |
| Total other income (expense), net | 1,767,776 | -354,059 | -2,114,617 | |
| Loss before (provision for) benefit from income taxes | -289,745 | -2,608,799 | -3,945,935 | |
| (provision for) benefit from income taxes | 0 | 4,484 | 13,505 | |
| Net loss | -289,745 | -2,613,283 | -3,959,440 | |
| Net income attributable to non-controlling interest | - | 0 | 0 | |
| Net loss attributable to stockholders | - | -2,613,283 | -3,959,440 | |
| Basic loss per common share (in dollars per share) | -0.02 | -0.16 | -0.24 | |
| Diluted loss per common share (in dollars per share) | -0.02 | -0.16 | -0.24 | |
| Weighted average number of common shares outstanding, basic (in shares) | 16,549,357 | 16,422,651 | 16,312,468 | |
| Weighted average number of common shares outstanding, diluted (in shares) | 16,549,357 | 16,422,651 | 16,312,468 | |
VSEE HEALTH, INC. (VSEEW)
VSEE HEALTH, INC. (VSEEW)